Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China
· Delayed Price · Currency is CNY 11.22
+0.41 (3.79%)
At close: Mar 10, 2026
SHE:300485 Revenue
Beijing Science Sun Pharmaceutical had revenue of 111.83M CNY in the quarter ending September 30, 2025, with 3.50% growth. This brings the company's revenue in the last twelve months to 402.23M, down -0.84% year-over-year. In the year 2024, Beijing Science Sun Pharmaceutical had annual revenue of 416.48M, down -12.61%.
Revenue (ttm)
402.23M
Revenue Growth
-0.84%
P/S Ratio
13.44
Revenue / Employee
784.07K
Employees
513
Market Cap
5.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 416.48M | -60.09M | -12.61% |
| Dec 31, 2023 | 476.57M | -257.98M | -35.12% |
| Jan 1, 2023 | 734.55M | -316.26M | -30.10% |
| Jan 1, 2022 | 1.05B | -43.42M | -3.97% |
| Dec 31, 2020 | 1.09B | -96.68M | -8.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Sinobioway Biomedicine | 257.74M |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Tianjin Lisheng Pharmaceutical | 1.32B |
| Teyi Pharmaceutical Group Co.,Ltd | 924.04M |
| Hubei Biocause Heilen Pharmaceutical | 430.77M |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.52B |